A major Phase 3 trial has reported better results than a standard wet-AMD injection, raising hopes for longer-lasting treatment with fewer rescue injections.

For decades, the root causes of dry age-related macular degeneration have been a black box.

Some new research from John Hopkins Medicine suggests that the presence of a specific protein may reveal whether a patient suffering from the wet form of age-related macular degeneration, may be safely weaned off treatment.

Macular Degeneration is the leading cause of blindness in the western world (JRSM, 2006), and is notoriously difficult to treat due to the limited understanding of the retina.

Happy National Eye Health Week! This week is about educating or refreshing our understanding of eye conditions and remembering to book an eye test.

Our eyes are truly amazing, so let’s look after them!

How could microRNA solve the UK’s leading cause of blindness in over 60s?

A large long-term study conducted by researchers from University College London has found that living in an area with high levels of air pollution can increase your risk of developing macular degeneration by 8%.

Scientists at University College London (UCL) have collaborated with the Western Eye Hospital, London, to develop a pioneering new eye test that may predict wet age-related macular degeneration (AMD) three years before symptoms begin to develop.

A new treatment for wet age-related macular degeneration could see patients receiving just four injections a year.